KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Illumina (ILMN) Cash & Equivalents (2016 - 2025)

Illumina (ILMN) has disclosed Cash & Equivalents for 17 consecutive years, with $1.0 billion as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 20.83% year-over-year to $1.0 billion, compared with a TTM value of $1.0 billion through Sep 2025, up 20.83%, and an annual FY2024 reading of $1.1 billion, up 7.54% over the prior year.
  • Cash & Equivalents was $1.0 billion for Q3 2025 at Illumina, up from $934.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.4 billion in Q2 2021 and bottomed at $869.0 million in Q3 2024.
  • Average Cash & Equivalents over 5 years is $1.5 billion, with a median of $1.1 billion recorded in 2024.
  • The sharpest move saw Cash & Equivalents soared 137.06% in 2021, then crashed 69.52% in 2022.
  • Year by year, Cash & Equivalents stood at $1.1 billion in 2021, then dropped by 7.41% to $1.0 billion in 2022, then increased by 4.8% to $1.0 billion in 2023, then rose by 7.54% to $1.1 billion in 2024, then decreased by 6.83% to $1.0 billion in 2025.
  • Business Quant data shows Cash & Equivalents for ILMN at $1.0 billion in Q3 2025, $934.0 million in Q2 2025, and $1.1 billion in Q1 2025.